OSE IMMUNO (OSE.PA) Stock Income Statement
EPA:OSE - Euronext Paris - Matif - FR0012127173 - Common Stock - Currency: EUR
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 83.44M | 2.23M | 18.30M | 26.31M | 10.43M | |||
| Gross Profit | N/A | N/A | N/A | 26.31M | 10.42M | |||
| Operating Expenses | 39.70M | 25.57M | 36.59M | 42.64M | 29.42M | |||
| Research and Development | 32.74M | 24.46M | 29.91M | 33.72M | 27.84M | |||
| Selling, General, and Administrative Expenses | 9.00M | 7.32M | 8.98M | 11.69M | 6.58M | |||
| Operating Income | 43.73M | -23.35M | -18.29M | -16.34M | -18.99M | |||
| Interest Income/Expense | -5.37M | -421.00K | 440.00K | -596.00K | -269.00K | |||
| Other Income/Expense | 1.47M | 186.00K | 14.00K | 8.00K | 12.00K | |||
| Non Recurring Items | 0.00 | 361.00K | -187.00K | -289.00K | N/A | |||
| Income Before Taxes | 39.83M | -23.22M | -18.02M | -17.21M | -19.25M | |||
| Income Tax | 2.39M | -219.00K | -263.00K | -364.00K | -2.69M | |||
| Net Income | 37.45M | -23.00M | -17.76M | -16.85M | -16.55M | |||
| EBITDA | 47.05M | -19.93M | -14.75M | -13.68M | -18.26M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.71 | -1.18 | -0.96 | -0.93 | -1.06 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | 100.02% | 99.88% | |||
| Profit Margin | 44.88% | -1032.91% | -97.04% | -64.05% | -158.69% | |||
| Operating Profit Margin | 52.42% | -1048.36% | -99.93% | -62.10% | -182.03% | |||
All data in EUR